Immuneering Operating Income vs Total Other Income Expense Net Analysis
| IMRX Stock | USD 2.08 0.02 0.95% |
Immuneering Corp financial indicator trend analysis is infinitely more than just investigating Immuneering Corp recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Immuneering Corp is a good investment. Please check the relationship between Immuneering Corp Operating Income and its Total Other Income Expense Net accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immuneering Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Immuneering Stock please use our How to Invest in Immuneering Corp guide.
Operating Income vs Total Other Income Expense Net
Operating Income vs Total Other Income Expense Net Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Immuneering Corp Operating Income account and Total Other Income Expense Net. At this time, the significance of the direction appears to have pay attention.
The correlation between Immuneering Corp's Operating Income and Total Other Income Expense Net is -0.93. Overlapping area represents the amount of variation of Operating Income that can explain the historical movement of Total Other Income Expense Net in the same time period over historical financial statements of Immuneering Corp, assuming nothing else is changed. The correlation between historical values of Immuneering Corp's Operating Income and Total Other Income Expense Net is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Operating Income of Immuneering Corp are associated (or correlated) with its Total Other Income Expense Net. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Other Income Expense Net has no effect on the direction of Operating Income i.e., Immuneering Corp's Operating Income and Total Other Income Expense Net go up and down completely randomly.
Correlation Coefficient | -0.93 |
| Relationship Direction | Negative |
| Relationship Strength | Significant |
Operating Income
Operating Income is the amount of profit realized from Immuneering Corp operations after accounting for operating expenses such as cost of goods sold (COGS), wages and depreciation. Operating income takes the gross income and subtracts other operating expenses and then removes depreciation. Operating Income of Immuneering Corp is typically a synonym for earnings before interest and taxes (EBIT) and is also commonly referred to as operating profit or recurring profit. Earnings before interest and taxes (EBIT), representing the amount of profit a company generates from its operations.Total Other Income Expense Net
Most indicators from Immuneering Corp's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Immuneering Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Immuneering Corp. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. For more information on how to buy Immuneering Stock please use our How to Invest in Immuneering Corp guide.At this time, Immuneering Corp's Tax Provision is fairly stable compared to the past year. Issuance Of Capital Stock is likely to rise to about 55.6 M in 2024, whereas Selling General Administrative is likely to drop slightly above 10.2 M in 2024.
| 2021 | 2022 | 2023 | 2024 (projected) | Total Operating Expenses | 34.8M | 51.9M | 58.4M | 37.5M | Cost Of Revenue | 1.2M | 158.1K | 764.1K | 732.6K |
Immuneering Corp fundamental ratios Correlations
Click cells to compare fundamentals
Immuneering Corp Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Immuneering Stock Analysis
When running Immuneering Corp's price analysis, check to measure Immuneering Corp's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immuneering Corp is operating at the current time. Most of Immuneering Corp's value examination focuses on studying past and present price action to predict the probability of Immuneering Corp's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immuneering Corp's price. Additionally, you may evaluate how the addition of Immuneering Corp to your portfolios can decrease your overall portfolio volatility.